Showing results (151-160 of 190) with videos related to
Sort By:
Pageof 19
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.Blood Advances|March 4, 2026
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.Blood Advances|January 7, 2026
Impact of Statin Use on Cardiovascular and Hematologic Outcomes Among Patients with Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomesJoan How, Orly Leiva, Robert Redd, et al.Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia VeraAlexander Coltoff, Ruben Mesa, Jason Gotlib, et al.Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.Cancer|July 13, 2019
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admissionSamuel D Slavin, Alyssa Fenech, Amanda L Jankowski, et al.Bone Marrow Transplantation|January 27, 2015
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allograftsG S Hobbs, A Hamdi, P D Hilden, et al.Blood Advances|September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosisRathnam K Venkat, Robert A Redd, Amyah C Harris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FBrady L Stein, Stephen T Oh, Dmitriy Berenzon, et al.Pageof 19